wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33394594-6DA03086-E493-407B-9A24-F269B830D364
Q33394594-6DA03086-E493-407B-9A24-F269B830D364
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33394594-6DA03086-E493-407B-9A24-F269B830D364
A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer.
P2860
Q33394594-6DA03086-E493-407B-9A24-F269B830D364
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33394594-6DA03086-E493-407B-9A24-F269B830D364
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d6b8484911f5865f35ba26e4267b77e3af9a0943
P2860
Gemcitabine: metabolism, mechanisms of action, and self-potentiation.